Introduction
============

Preclinical and clinical studies report that β-blockers may be an interesting option to attenuate the deleterious effects of prolonged catecholamine exposure during septic shock. Nevertheless, there are concerns that β-blockers may have negative chronotropic and inotropic effects leading to inappropriately low cardiac output. The objective of the present study was therefore to elucidate whether a reduction in heart rate (HR) with esmolol may negatively affect microcirculation in patients with septic shock who remained tachycardic after hemodynamic optimization.

Methods
=======

After 36 hours of initial hemodynamic stabilization, 11 septic shock patients with HR \>95 bpm and requiring norepinephrine (NE) to maintain mean arterial pressure (MAP) between 65 and 75 mmHg, despite adequate volume resuscitation, received a continuous esmolol infusion to maintain HR between 94 and 80 bpm. NE was titrated to achieve a MAP between 65 and 75 mmHg. Data from right heart catheterization and sidestream dark-field imaging were obtained at baseline and after 24 hours.

Results
=======

Apart from a statistically significant decrease in HR and cardiac index (CI) (*P*\< 0.05), stroke volume (SV), microvascular flow index of the small vessels (MFIs) and norepinephrine requirements did not vary during the 24-hour observational period. Results are summarized in Table [1](#T1){ref-type="table"}.

         Baseline    24 hours
  ------ ----------- -----------
  HR     119 ± 12    85 ± 9\*
  CI     4.4 ± 1     3.1 ± 1\*
  SV     81 ± 35     80 ± 23
  MFIs   2.6 ± 0.6   2.8 ± 0.3
  NE     0.7 ± 0.7   0.5 ± 0.4

\**P*\< 0.05.

Conclusion
==========

In patients with established septic shock who remained tachycardic after hemodynamic optimization in accordance with the current guidelines, titration of esmolol to reduce the HR to a predefined threshold did not affect microcirculatory blood flow.
